國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 851553      在线人数 : 889
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版

    子类别

    期刊論文 [27/27]
    會議論文/會議摘要 [5/7]

    邻近社群


    于重元 [19/19]
    劉柯俊 [85/98]
    劉滄梧 [119/125]
    劉界元(2003-2010) [3/3]
    夏和雄(1996-2012) [26/31]
    夏興國 [51/54]
    姜乃榕 [82/94]
    常慧如 [39/44]
    張俊彥 [234/254]
    張光裕 [69/79]
    張憶壽 [103/106]
    張文祥 [52/53]
    張書銘 [89/91]
    彭汪嘉康(1996-2007) [120/126]
    施能耀 [37/43]
    李家惠 [29/29]
    李岳倫 [48/49]
    林素芳 [32/32]
    楊奕馨 [41/42]
    江士昇 [88/90]
    沈哲宏 [14/16]
    洪文俊 [88/88]
    莊雙恩 [82/91]
    蔡慧珍 [66/71]
    蘇勇曄 [40/40]
    蘇振良 [24/25]
    郭靜娟 [71/76]
    陳尚鴻 [45/48]
    陳振陽 [72/72]
    陳立宗 [443/510]
    陳美霞(2002-2009) [1/1]
    陳詩政 [2/2]
    陳雅雯 [38/39]
    黃智興 [55/55]
    黃道揚 [26/26]
    丁兆治(2000-2004) [5/5]
    其他 [464/471]
    劉敏(1996-2007) [60/62]
    劉玫英(2004-2006) [2/2]
    吳成文(1996-2008) [53/55]
    曾思文(1997-2007) [4/4]
    李冠德(1997-2004) [4/6]
    林景太(1999-2007) [5/5]
    楊文光(1996-1999) [21/21]
    王全正(1996-2003) [4/4]
    莊聲宏(1997-2004) [11/11]
    詹宗晃(2000-2008) [2/2]
    賴基銘(2004-2008) [41/47]
    阮麗蓉(2000-2006) [6/7]
    陳俊叡(2003-2007) [6/6]
    馬彥英(1997-1999) [1/1]
    黃奇英(2005-2007) [9/10]

    社群统计


    近3年内发表的文件:2(5.88%)
    含全文笔数:32(94.12%)

    文件下载次数统计
    下载大于0次:32(100.00%)
    下载大于100次:31(96.88%)
    全文下载总次数:13966(0.26%)

    最后更新时间: 2024-11-28 15:38

    上传排行

    数据加载中.....

    下载排行

    数据加载中.....

    RSS Feed RSS Feed
    跳至:
    或输入年份:
    由新到旧排序 由最旧的开始

    显示项目1-34 / 34. (共1页)
    1 
    每页显示[10|25|50]项目

    日期题名關聯
    2023-09-15 Oncogenic ASPM is a regulatory hub of developmental and stemness signaling in cancers Cancer Research. 2023 Sep 15;83(18):2993-3000.
    2023-03 ASPM activates Hedgehog and Wnt signaling to promote small cell lung cancer stemness and progression Cancer Research. 2023 Mar 15;83(6):830-844.
    2021-06-22 A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells [Erratum:Frontiers in Oncology. 2021 May 31;11:Article number 638311.] Frontiers in Oncology. 2021 Jun 22;11:Article number 718849.
    2021-05-31 A novel invadopodia-specific marker for invasive and pro-metastatic cancer stem cells Frontiers in Oncology. 2021 May 31;11:Article number 638311.
    2021-05 A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer Gastric Cancer. 2021 May;24(3):624-639.
    2021-05 A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer[Erratum:Gastric Cancer. 2021 May;24(3):624-639.] Gastric Cancer. 2021 May;24(3):640-641.
    2020-03-10 Dishevelled 1-regulated superpotent cancer stem cells mediate wnt heterogeneity and tumor progression in hepatocellular carcinoma Stem Cell Reports. 2020 Mar 10;14(3):462-477.
    2020-02 The multifaceted role of mesenchymal stem cells in cancer Seminars in Cancer Biology. 2020 Feb;60:225-237.
    2020-01 A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study European Journal of Cancer. 2020 Jan;124:123-130.
    2019-12 The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis Journal of Pathology. 2019 Dec;249(4):498-508.
    2019-11-13 Histone demethylase KDM4C stimulates the proliferation of prostate cancer cells via activation of AKT and c-Myc Cancers. 2019 Nov 13;11(11):Article number 1785.
    2019-07 Targeting the interplay between cancer fibroblasts, mesenchymal stem cells, and cancer stem cells in desmoplastic cancers Frontiers in Oncology. 2019 Jul;9:Article number 688.
    2019-05-17 Next viable routes to targeting pancreatic cancer stemness: Learning from clinical setbacks Journal of Clinical Medicine. 2019 May 17;8(5):Article number 702.
    2019-02 ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling Oncogene. 2019 Feb;38(8):1340-1353.
    2019-02 ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling [Erratum: Oncogene. 2019 Feb;38(8):1340-1353.] Oncogene. 2019 Feb;38(8):1354.
    2018-12 ACTL6a promotes metastasis and predicts poor prognosis of prostate cancer via regulation of YAP and cancer stemness Cancer Science. 2018 Dec;109(Suppl. 2):244.
    2018-11 Targeting PTX3 can prevent drug-resistant cancer progression Protein Science. 2018 Nov;27(Suppl. 1):24.
    2018-10 Multicenter, phase II trial of biweekly S-1, leucovorin (LV), oxaliplatin and gemcitabine (SLOG) in metastatic pancreatic adenocarcinoma (mPDAC): Final report of TCOG T1211 study Annals of Oncology. 2018 Oct;29(Suppl. 8):Meeting Abstract 736P.
    2017-11 Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma Biochemical and Biophysical Research Communications. 2017 Nov;493(1):14-19.
    2017-05 Metronomic chemotherapy: Direct targeting of cancer cells after all? Trends in Cancer. 2017 May;3(5):319-325.
    2016-12 Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells Journal of Experimental Medicine. 2016 Dec;213 (13):2967-2988.
    2016-12 NCoR2 mediates death-resistance and mechano-regulation of glioblastoma multiforme Molecular Biology of the Cell. 2016 Dec;27:Meeting Abstract P1160.
    2016-02 Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC) Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 369.
    2015-11 Proteomics profiling of epigenetic proteins during acinar morphogenesis to identify prostate cancer prognostic markers Annals of Oncology. 2015 Nov;26:vii106-vii151.
    2015-09 Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers Oncotarget. 2015 Sep;6(27):23987-24001.
    2014-07 Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression Breast Cancer Research. 2014 Jul;16(4):Article number 410.
    2013-11 A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression Gastroenterology. 2013 Nov;145(5):1110-1120.
    2013-06-13 Cholestane-3beta, 5alpha, 6beta-triol suppresses proliferation, migration, and invasion of human prostate cancer cells PLoS ONE. 2013 Jun 13;8(6):Article number e65734.
    2013-05 Complete microscale profiling of tumor microangiogenesis: A microradiological methodology reveals fundamental aspects of tumor angiogenesis and yields an array of quantitative parameters for its characterization Biotechnology Advances. 2013 May;31(3):396-401.
    2013-02 Molecular profiling of prostatic acinar morphogenesis identifies PDCD4 and KLF6 as tissue architecture-specific prognostic markers in prostate cancer American Journal of Pathology. 2013 Feb;182(2):363-374.
    2012-12 A molecular signature of tubulogenesis in pancreatic cancer and oncogenic role of ASPM Molecular Biology of the Cell. 2012 Dec;23:Article number 1631.
    2012-08-14 Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan Proceedings of the National Academy of Sciences of the United States of America. 2012 Aug 14;109(33):13231-13236.
    2012-08 Krüppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma American Journal of Pathology. 2012 Aug;181(2):423-430.
    2012-05 The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis Cell. 2012 May;149(5):1098-1111.

    显示项目1-34 / 34. (共1页)
    1 
    每页显示[10|25|50]项目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈